Search

Author/Creator Mardekian, J.

2. Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis. (4th March 2018)

Authors:
Deitelzweig, S.; Farmer, C.; Luo, X.; Li, X.; Vo, L.; Mardekian, J.; Fahrbach, K.; Ashaye, A.
Journal:
Current medical research and opinion
Issue:
Volume 34:Number 3(2018)
Page Start:
487
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. FRI0443 Impact of etanercept therapy on disease activity and health-related quality of life of a moderate rheumatoid arthritis patient population from a national british observational cohort. (23rd January 2014)

Authors:
Kotak, S.; Mardekian, J.; Horowicz-Mehler, N.; Shah, A.; Burgess, A.; Kim, J.; Gemmen, E.; Boyd, H.; Koenig, A.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
464
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study. (16th July 2020)

Authors:
Lip, G. Y. H.; Keshishian, A. V.; Kang, A. L.; Dhamane, A. D.; Luo, X.; Li, X.; Balachander, N.; Rosenblatt, L.; Mardekian, J.; Pan, X.; Di Fusco, M.; Garcia Reeves, A. B.; Yuce, H.; Deitelzweig, S.
Journal:
Journal of internal medicine
Issue:
Volume 289:Number 1(2021)
Page Start:
42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗